购物车
- 全部删除
- 您的购物车当前为空
AR antagonist 10 (Compound Y5) 是一种高效的口服雄激素受体 (Androgen receptor(AR)) 拮抗剂,IC50为0.04 μM。此化合物通过干扰AR二聚化和诱导AR降解的双重机制来对抗AR。对多种耐药性AR突变体具有显著活性,并能有效抑制LNCaP异种移植瘤的生长,适用于耐药性前列腺癌的研究。
AR antagonist 10 (Compound Y5) 是一种高效的口服雄激素受体 (Androgen receptor(AR)) 拮抗剂,IC50为0.04 μM。此化合物通过干扰AR二聚化和诱导AR降解的双重机制来对抗AR。对多种耐药性AR突变体具有显著活性,并能有效抑制LNCaP异种移植瘤的生长,适用于耐药性前列腺癌的研究。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | 待询 | 10-14周 | |
50 mg | 待询 | 10-14周 |
产品描述 | AR antagonist 10 (Compound Y5) is a potent, orally active androgen receptor (AR) antagonist with an IC50 value of 0.04 μM. It demonstrates a dual mechanism of action: antagonizing AR by disrupting AR dimerization and inducing AR degradation through the ubiquitin-proteasome pathway. This compound shows excellent activity against various resistant AR mutants and effectively inhibits the growth of LNCaP xenograft tumors. AR antagonist 10 is applicable for research in resistant prostate cancer. |
分子量 | 404.871 |
分子式 | C18H17ClN4O3S |
CAS No. | 3068489-78-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容